Beta test for The Choral Hub’s gamification of singing skills
The Choral Hub has submitted its singing for wellness app, Tchzant, for Beta testing prior to a planned summer launch.
Sano Genetics targets $113bn market after $11m Series A
Cambridge University HealthTech spin-out Sano Genetics has raised $11 million Series A cash to accelerate research into Long Covid, MS, Parkinson’s and other chronic conditions.
Arecor scoops two awards at CambridgeshireLive Business Awards
Arecor Therapeutics PLC (AIM:AREC) announced it won the HCR Hewitsons Award of Innovation in Business today.
Eagle Genomics listed as Top Global FoodTech Company in FoodTech 500
Eagle Genomics, a software business pioneering the application of network science to biology, was pleased to announce that it has been recognized by AgriFoodTech organization Forward Fooding as a 'The FoodTech 500' company.
Paragraf Proves the Viability of Graphene for In-Vitro Diagnostics
After a successful Series B funding round, Paragraf is ready to take on bigger challenges—venturing into graphene-based biosensing.
Computational drug discovery expert takes new role at Healx
World-renowned computational drug discovery expert, Nathan Brown, has joined the team of Cambridge-based rare disease drug specialist Healx as director of digital chemistry.
Formula 1 and Frontier Developments unveil F1® Manager 2022 video game
Formula 1 and Frontier Developments today unveiled F1® Manager 2022, the first management simulation game as part of a long term, multi-title agreement, set for release in the summer of 2022.
Tenyks lands $3.4m for human-AI interaction to fend off the ‘terminator’
Tenyks, a University of Cambridge spin-out focused on helping machine learning engineers build better, safer AI, has raised an impressive $3.4 million seed round.
Paragraf raises $60m as graphene-based electronics company sets sights on international growth
The funding round, which includes current investors Parkwalk and Amadeus, will enable the business to increase its technological capacity globally and enhance its R&D capabilities.
Top 5 companies delivering a sustainable pandemic recovery
Innovative companies are key to sustainable economic recovery post pandemic, according to Innovate UK’s Jonny Voon. Here are his top 5 sustainable businesses leading the charge…
Healx’s AI Platform Draws Novel Connections in Myriad Rare Diseases
February 28 was Rare Disease Day, a movement intentionally scheduled on the rarest day of the year to raise international awareness surrounding rare diseases.
PhoreMost promotes Dr Neil Torbett to Chief Executive Officer
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, announces the promotion of Dr Neil Torbett to Chief Executive Officer, with immediate effect. Dr Torbett was previously the Company’s Chief Operating Officer. Founder and former CEO, Dr Chris Torrance will become Chair of the Board.
Magyar Bankholding picks Thought Machine as digital banking partner
Magyar Bankholding Group has chosen the London-based Thought Machine as its partner to launch its new digital banking world, becoming the first domestic bank to use this technology, according to a press release sent to the Budapest Business Journal.
Italy’s largest bank pumps £40m into Thought Machine
Intesa Sanpaolo to launch entirely new digital bank using London-headquartered firm’s core banking engine Vault
Mental health assessment platform opened up to individual users
Cambridge-based HealthTech company Psyomics, has opened up access to its online mental health assessment platform Censeo for the first time to individual users.
Paragraf's Graphene Sensor Stays Cool for Quantum Computing
Paragraf is a Cambridge-based startup that was spun out of Cambridge University's Department of Materials Engineering.
Healx bites into Big Apple pharma in novel rare disease quest
Cambridge rare disease thought leader Healx has secured potentially game and life-changing technology from Wall Street-quoted biopharma company Ovid Therapeutics.
Healx and Ovid Therapeutics enter strategic partnership
Ovid Therapeutics, a biopharmaceutical company committed to developing medicines that transform the lives of people with neurological diseases, and Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, announces that Healx has secured from Ovid an exclusive option to license rights to develop and commercialize gaboxadol.
Hoteliers Count the Costs of Bed Bugs
Hotels can now assess the cost of bed bugs to their bottom line with a newly launched free online tool from Spotta Smart Pest Systems
Audio Analytic feature on the popular AI Podcast with Noah Kravitz
From active noise cancellation to digital assistants that are always listening for your commands, audio is perhaps one of the most important but often overlooked aspects of modern technology in our daily lives.